Chiracon is the global point of contact for the production of high-quality intermediate and end products for the pharmaceutical industry.
Chiracon offers the pharmaceutical industry many years of know-how in the field of drug synthesis. Combined with a management system that incorporates the GMP environment built into an ISO 9001 system, Chiracon can partner with drug development projects and new or generic products. Chiracon also offers the creation of ASMF / DMF and CMC / IMPD documentation. They are also happy to take on custom syntheses.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 1, 2005 | Series Unknown | — | 1 | Triginta Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Triginta Capital | Yes | Series Unknown |